<DOC>
	<DOCNO>NCT00237809</DOCNO>
	<brief_summary>This study base hypothesis increase N-methyl-D-aspartic acid ( NMDA ) receptor function brain thereby increase capacity brain form new connection strengthen exist connection , schizophrenic patient may derive great sustain benefit cognitive retraining .</brief_summary>
	<brief_title>D-Serine Treatment Negative Symptoms Cognitive Deficits Schizophrenia</brief_title>
	<detailed_description>Patients schizophrenia schizoaffective disorder currently receive antipsychotic medication randomly assign double-blind manner receive either D-serine ( 30 mg/kg ) placebo addition cognitive rehabilitation non-interactive placebo 12 week .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>Diagnosis schizophrenia schizoaffective disorder Exclusion Pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>